Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.930
-0.070 (-2.33%)
At close: Jun 23, 2025, 4:00 PM
2.920
-0.010 (-0.34%)
After-hours: Jun 23, 2025, 7:02 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $40.19 million as of June 23, 2025. Its market cap has increased by 47.46% in one year.
Market Cap
40.19M
Enterprise Value
18.88M
1-Year Change
47.46%
Ranking
Category
Stock Price
2.93
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $40.19M, a decrease of -53.91%. That is a compound annual growth rate of -5.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.26B |
| Johnson & Johnson | 362.45B |
| Novo Nordisk | 326.28B |
| AbbVie | 326.18B |
| UnitedHealth Group | 271.61B |
| Abbott Laboratories | 231.92B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |